Health

Israel’s Oramed Says Oral Insulin Capsule Trial a Success

Jan 30 (Reuters) – Oramed, an Israeli developer of oral drug delivery systems, said on Thursday a mid-stage trial for its oral insulin capsule for the treatment of type 2 diabetes met all primary and secondary endpoints. During the Phase 2a trial, conducted under a Read More

Advertisements